543 related articles for article (PubMed ID: 31731193)
1. Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages.
Zhou Y; Zhang CY; Duan JX; Li Q; Yang HH; Sun CC; Zhang J; Luo XQ; Liu SK
Biomed Pharmacother; 2020 Jan; 121():109596. PubMed ID: 31731193
[TBL] [Abstract][Full Text] [Related]
2. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX
Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759
[TBL] [Abstract][Full Text] [Related]
3. Aloin suppresses lipopolysaccharide-induced acute lung injury by inhibiting NLRP3/NF-κB via activation of SIRT1 in mice.
Lei J; Shen Y; Xv G; Di Z; Li Y; Li G
Immunopharmacol Immunotoxicol; 2020 Aug; 42(4):306-313. PubMed ID: 32419528
[TBL] [Abstract][Full Text] [Related]
4. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.
Jiang L; Zhang L; Kang K; Fei D; Gong R; Cao Y; Pan S; Zhao M; Zhao M
Biomed Pharmacother; 2016 Dec; 84():130-138. PubMed ID: 27643555
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide overexpression mediated by lentivirus attenuates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation.
Sun GY; Yang HH; Guan XX; Zhong WJ; Liu YP; Du MY; Luo XQ; Zhou Y; Guan CX
Mol Immunol; 2018 May; 97():8-15. PubMed ID: 29544087
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroids alleviate lipopolysaccharide-induced inflammation and lung injury via inhibiting NLRP3-inflammasome activation.
Yang JW; Mao B; Tao RJ; Fan LC; Lu HW; Ge BX; Xu JF
J Cell Mol Med; 2020 Nov; 24(21):12716-12725. PubMed ID: 32977368
[TBL] [Abstract][Full Text] [Related]
8. Fn14 exacerbates acute lung injury by activating the NLRP3 inflammasome in mice.
Guan XX; Yang HH; Zhong WJ; Duan JX; Zhang CY; Jiang HL; Xiang Y; Zhou Y; Guan CX
Mol Med; 2022 Jul; 28(1):85. PubMed ID: 35907805
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glycolysis alleviates lipopolysaccharide-induced acute lung injury in a mouse model.
Zhong WJ; Yang HH; Guan XX; Xiong JB; Sun CC; Zhang CY; Luo XQ; Zhang YF; Zhang J; Duan JX; Zhou Y; Guan CX
J Cell Physiol; 2019 Apr; 234(4):4641-4654. PubMed ID: 30256406
[TBL] [Abstract][Full Text] [Related]
10. RIP3 dependent NLRP3 inflammasome activation is implicated in acute lung injury in mice.
Chen J; Wang S; Fu R; Zhou M; Zhang T; Pan W; Yang N; Huang Y
J Transl Med; 2018 Aug; 16(1):233. PubMed ID: 30126430
[TBL] [Abstract][Full Text] [Related]
11. Epoxyeicosatrienoic acids inhibit the activation of NLRP3 inflammasome in murine macrophages.
Luo XQ; Duan JX; Yang HH; Zhang CY; Sun CC; Guan XX; Xiong JB; Zu C; Tao JH; Zhou Y; Guan CX
J Cell Physiol; 2020 Dec; 235(12):9910-9921. PubMed ID: 32452554
[TBL] [Abstract][Full Text] [Related]
12. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
[TBL] [Abstract][Full Text] [Related]
13. Cyclic helix B peptide alleviates sepsis-induced acute lung injury by downregulating NLRP3 inflammasome activation in alveolar macrophages.
Zhang XP; Zhang WT; Qiu Y; Ju MJ; Yang C; Tu GW; Luo Z
Int Immunopharmacol; 2020 Nov; 88():106849. PubMed ID: 32795894
[TBL] [Abstract][Full Text] [Related]
14. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
[TBL] [Abstract][Full Text] [Related]
15. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury
Han S; Yuan R; Cui Y; He J; Wang QQ; Zhuo Y; Yang S; Gao H
Front Immunol; 2022; 13():846384. PubMed ID: 35281058
[TBL] [Abstract][Full Text] [Related]
16. A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation.
Yang HH; Duan JX; Liu SK; Xiong JB; Guan XX; Zhong WJ; Sun CC; Zhang CY; Luo XQ; Zhang YF; Chen P; Hammock BD; Hwang SH; Jiang JX; Zhou Y; Guan CX
Theranostics; 2020; 10(11):4749-4761. PubMed ID: 32308747
[No Abstract] [Full Text] [Related]
17. Dynasore Alleviates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.
Shan M; Wan H; Ran L; Ye J; Xie W; Lu J; Hu X; Deng S; Zhang W; Chen M; Wang F; Guo Z
Drug Des Devel Ther; 2024; 18():1369-1384. PubMed ID: 38681210
[TBL] [Abstract][Full Text] [Related]
18. Bavachin attenuates LPS-induced inflammatory response and inhibits the activation of NLRP3 inflammasome in macrophages.
Hung YL; Wang SC; Suzuki K; Fang SH; Chen CS; Cheng WC; Su CC; Yeh HC; Tu HP; Liu PL; Huang MY; Li CY
Phytomedicine; 2019 Jun; 59():152785. PubMed ID: 31009850
[TBL] [Abstract][Full Text] [Related]
19. Loganin alleviates sepsis-induced acute lung injury by regulating macrophage polarization and inhibiting NLRP3 inflammasome activation.
Zhang J; Wang C; Wang H; Li X; Xu J; Yu K
Int Immunopharmacol; 2021 Jun; 95():107529. PubMed ID: 33744777
[TBL] [Abstract][Full Text] [Related]
20. Aloperine alleviates lipopolysaccharide-induced acute lung injury by inhibiting NLRP3 inflammasome activation.
Zeng J; Liu J; Huang JH; Fu SP; Wang XY; Xi C; Cui YR; Qu F
Int Immunopharmacol; 2023 Jul; 120():110142. PubMed ID: 37210910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
